WANY
KRRO icon

Wealthspire Advisors (New York)’s Korro Bio KRRO Stock Holding History

Wealthspire Advisors (New York)’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-65
Closed -$3.11K – 2029
2025
Q3 		$3.11K Buy
+65
New +$1.44K ﹤0.01% 2474

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Wealthspire Advisors (New York)'s KRRO Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Korro Bio (KRRO) in Q4 2025, closing a stake of 65 shares — an estimated $3.11K sold.

Wealthspire Advisors (New York) first reported a position in KRRO in Q3 2025 and held it in 1 quarter. The position peaked at $3.11K in Q3 2025. 83 funds tracked by Wall St. Rank hold KRRO as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Korro Bio position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 65 Korro Bio shares in Q4 2025, an estimated $3.11K.
  • Wealthspire Advisors (New York) first reported a position in Korro Bio in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Korro Bio position peaked at $3.11K in Q3 2025.
  • 83 funds tracked by Wall St. Rank held Korro Bio as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.